Botulinum toxin A for drooling in Parkinson's disease: A pilot study to compare submandibular to parotid gland injections

Parkinsonism and Related Disorders

Volumn 13, Issue 8, 2007, Pages 532-534

  Kalf, Johanna G ^a   Smit, Anne M ^a   Bloem, Bastiaan R ^a   Zwarts, Machiel J ^a   Mulleners, Wim M ^b   Munneke, Marten ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Botulinum neurotoxin; Drooling; Parkinson's disease; Submandibular glands versus parotid glands

Indexed keywords

BOTULINUM TOXIN A;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DYSPHAGIA; FEMALE; HUMAN; HYPERSALIVATION; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PAROTID GLAND; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBMANDIBULAR GLAND; XEROSTOMIA;

AGED; BOTULINUM TOXIN TYPE A; DRUG ADMINISTRATION ROUTES; HUMANS; MIDDLE AGED; NEUROMUSCULAR AGENTS; PARKINSON DISEASE; PAROTID GLAND; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SUBMANDIBULAR GLAND;

EID: 34250369768     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.01.007     Document Type: Article

References (12)

1. Kalf JG, Smit AM, Bloem BR, Zwarts MJ, Munneke M. Impact of drooling in Parkinson's disease. J Neurol 2007, in press.
2. Tan E.K. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations. Eur J Neurol 13 Suppl. 1 (2006) 60-64
3. Pedersen A.M., Bardow A., Jensen S.B., and Nauntofte B. Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral Dis 8 (2002) 117-129
4. Sreebny L.M. The salivary system (1987), CRC Press, Boca Raton, FL
5. Jongerius P.H., van den Hoogen F.J., van Limbeek J., Gabreels F.J., van Hulst K., and Rotteveel J.J. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 114 (2004) 620-627
6. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
7. Thomas-Stonell N., and Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 3 (1988) 73-78
8. Lipp A., Trottenberg T., Schink T., Kupsch A., and Arnold G. A randomized trial of botulinum toxin A for treatment of drooling. Neurology 61 (2003) 1279-1281
9. Lim M., Mace A., Reza Nouraei S.A., and Sandhu G. Botulinum toxin in the management of sialorrhoea: a systematic review. Clin Otolaryngol 31 (2006) 267-272
10. Lagalla G., Millevolte M., Capecci M., Provinciali L., and Ceravolo M.G. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study. Mov Disord 21 (2006) 704-707
11. Ellies M., Gottstein U., Rohrbach-Volland S., Arglebe C., and Laskawi R. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis. Laryngoscope 114 (2004) 1856-1860
12. Tumilasci O.R., Cersosimo M.G., Belforte J.E., Micheli F.E., Benarroch E.E., and Pazo J.H. Quantitative study of salivary secretion in Parkinson's disease. Mov Disord 21 (2006) 660-667